BMS Presents Two Late-Breaking Presentations Demonstrating Sotyktu (deucravacitinib) Efficacy in Psoriatic Arthritis and Systemic Lupus Erythematosus ...
All myositis patients in the Phase 1/2 DM/ASyS cohort with sufficient follow-up who met key registrational inclusion criteria exceeded the registrational primary endpoint, demonstrating major TIS resp ...
BUSAN Jockey Ruan Maia secured his first Group success in Korea during his one-day visit to Busan on Oct 26 by partnering the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback